Published in J Pediatr on February 01, 1992
Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev (2000) 4.59
B-cell responses to vaccination at the extremes of age. Nat Rev Immunol (2009) 2.50
Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines. Nat Rev Immunol (2009) 2.11
Haemophilus influenzae type b conjugate vaccines. Immunology (2004) 1.37
Kinetics and avidity of antibodies evoked by heptavalent pneumococcal conjugate vaccines PncCRM and PncOMPC in the Finnish Otitis Media Vaccine Trial. Infect Immun (2005) 1.21
Characterization of anticapsular monoclonal antibodies that regulate activation of the complement system by the Cryptococcus neoformans capsule. Infect Immun (1998) 1.19
Nutritionally mediated programming of the developing immune system. Adv Nutr (2011) 1.16
Opposite effects of actively and passively acquired immunity to the carrier on responses of human infants to a Haemophilus influenzae type b conjugate vaccine. Infect Immun (1994) 1.05
Current status of meningococcal group B vaccine candidates: capsular or noncapsular? Clin Microbiol Rev (1994) 0.94
The acylated form of protein D of Haemophilus influenzae is more immunogenic than the nonacylated form and elicits an adjuvant effect when it is used as a carrier conjugated to polyribosyl ribitol phosphate. Infect Immun (1997) 0.93
Variable region sequences of a protective human monoclonal antibody specific for the Haemophilus influenzae type b capsular polysaccharide. Infect Immun (1994) 0.92
Protein carriers of conjugate vaccines: characteristics, development, and clinical trials. Hum Vaccin Immunother (2013) 0.89
Safety and immunogenicity of an investigational 4-component Staphylococcus aureus vaccine with or without AS03B adjuvant: Results of a randomized phase I trial. Hum Vaccin Immunother (2015) 0.85
Immunogenicity and safety of two different Haemophilus influenzae type b conjugate vaccines in Korean infants. J Korean Med Sci (2008) 0.85
Paediatrics--Part II. Postgrad Med J (1993) 0.84
Can Haemophilus influenzae type b-tetanus toxoid conjugate vaccine be combined with diphtheria toxoid-pertussis vaccine-tetanus toxoid? CMAJ (1993) 0.83
Active immunization in the United States: developments over the past decade. Clin Microbiol Rev (2001) 0.80
The V-region repertoire of Haemophilus influenzae type b polysaccharide antibodies induced by immunization of infants. Infect Immun (1995) 0.80
Immunogenicity of Haemophilus influenzae type b conjugate vaccines in Korean infants: a meta-analysis. J Korean Med Sci (2009) 0.79
Statement on Haemophilus influenzae type b conjugate vaccines for use in infants and children. CMAJ (1993) 0.77
Effect of increased CRM₁₉₇ carrier protein dose on meningococcal C bactericidal antibody response. Clin Vaccine Immunol (2012) 0.75
Timing of the booster dose with Haemophilus polyribosylribitol phosphate conjugated with Neisseria outer-membrane protein. J Pediatr (1992) 0.75
A novel progressive spongiform encephalopathy in cattle. Vet Rec (1987) 4.39
Broader autism phenotype: evidence from a family history study of multiple-incidence autism families. Am J Psychiatry (1997) 3.60
Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants. Pediatrics (1998) 3.13
Unaltered susceptibility to BSE in transgenic mice expressing human prion protein. Nature (1996) 3.09
An autosomal genomic screen for autism. Collaborative linkage study of autism. Am J Med Genet (1999) 3.07
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials. Lancet (2015) 2.70
Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease: background, evolution, and current concerns. Emerg Infect Dis (2001) 2.62
Periodic fever syndrome in children. J Pediatr (1999) 2.62
High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med (1987) 2.32
Acellular pertussis vaccines for infants. N Engl J Med (1996) 2.29
Objective system for interviewer performance evaluation for use in epidemiologic studies. Am J Epidemiol (1994) 2.28
Natural history of pertussis antibody in the infant and effect on vaccine response. J Infect Dis (1990) 2.18
Developmental and neurological progress of preterm infants with intraventricular haemorrhage and ventricular dilatation. Arch Dis Child (1982) 2.12
Course of behavioral change in autism: a retrospective study of high-IQ adolescents and adults. J Am Acad Child Adolesc Psychiatry (1996) 2.09
The seroepidemiology of Bordetella pertussis infections: a study of persons ages 1-65 years. J Infect Dis (1996) 2.06
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet (2015) 2.05
Energy and environment. Methane leaks from North American natural gas systems. Science (2014) 2.05
An MRI study of brain size in autism. Am J Psychiatry (1995) 1.92
Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience. Pediatr Infect Dis J (2001) 1.90
Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease. Nat Med (1997) 1.88
Cadherin function is required for axon outgrowth in retinal ganglion cells in vivo. Neuron (1996) 1.87
Psychiatric disorder and the broad autism phenotype: evidence from a family study of multiple-incidence autism families. Am J Psychiatry (1999) 1.86
Pertussis infection in adults with persistent cough. JAMA (1995) 1.84
Streptococcus pneumoniae colonization in the young child: association with otitis media and resistance to penicillin. J Pediatr (1995) 1.84
Personality and language characteristics in parents from multiple-incidence autism families. Am J Med Genet (1997) 1.78
Adenovirus infections in young children. Pediatrics (1985) 1.76
Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections. Pediatr Infect Dis J (1999) 1.75
Interlaboratory study evaluating quantitation of antibodies to Haemophilus influenzae type b polysaccharide by enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol (1996) 1.71
Severe ehrlichiosis in an adolescent taking trimethoprim-sulfamethoxazole. Pediatr Infect Dis J (2000) 1.66
Immunity to cross-reactive serotypes induced by pneumococcal conjugate vaccines in infants. J Infect Dis (1999) 1.63
Prevalence and incidence of adult pertussis in an urban population. JAMA (1996) 1.62
Expression of an antisense hla fragment in Staphylococcus aureus reduces alpha-toxin production in vitro and attenuates lethal activity in a murine model. Infect Immun (1997) 1.56
Description and evaluation of serologic assays used in a multicenter trial of acellular pertussis vaccines. Pediatrics (1995) 1.52
Twenty years of outpatient respiratory syncytial virus infection: a framework for vaccine efficacy trials. Pediatrics (1997) 1.51
Combination vaccines: problems and promise. J Pediatr (2000) 1.51
Filter paper blood collection and punching as a means of quantification. Clin Chem (1969) 1.49
The ecology of childhood overweight: a 12-year longitudinal analysis. Int J Obes (Lond) (2007) 1.48
Influence of feeding regimen on body condition in the cat. J Small Anim Pract (2000) 1.45
Syndrome of periodic fever, pharyngitis, and aphthous stomatitis. J Pediatr (1987) 1.44
Interchangeability of conjugated Haemophilus influenzae type b vaccines in infants. JAMA (1995) 1.40
The Hammer and the Heritage. Can Med Assoc J (1962) 1.39
Diphtheria outbreaks in immunized populations. N Engl J Med (1988) 1.38
A global paleoclimate observing system. Science (2001) 1.38
Use of C-arm fluoroscope to examine patients with swallowing disorders. AJR Am J Roentgenol (1990) 1.38
SQUID-based microwave cavity search for dark-matter axions. Phys Rev Lett (2010) 1.36
Pili and outer membrane appendages on Neisseria meningitidis in the cerebrospinal fluid of an infant. J Infect Dis (1982) 1.34
Serologic responses to Bartonella and Afipia antigens in patients with cat scratch disease. Pediatrics (1995) 1.33
Multicenter evaluating of a commercially available PCR assay for diagnosing enterovirus infection in a panel of cerebrospinal fluid specimens. J Clin Microbiol (1996) 1.32
Comparison of 13 acellular pertussis vaccines: adverse reactions. Pediatrics (1995) 1.29
Estimating the undetected burden of influenza hospitalizations in children. Epidemiol Infect (2006) 1.29
Parapneumonic empyema in children: decortication hastens recovery in patients with severe pleural infections. Pediatr Infect Dis J (1991) 1.26
Listeria monocytogenes infection in bovine mastitis. Vet Rec (1980) 1.25
1755 and all that: a historical primer of transmissible spongiform encephalopathy. BMJ (1999) 1.24
Immunologic and molecular biologic studies of prion proteins in bovine spongiform encephalopathy. J Infect Dis (1993) 1.24
Multicenter quality assessment of PCR methods for detection of enteroviruses. J Clin Microbiol (1999) 1.23
Clones of Streptococcus pneumoniae isolated from nasopharyngeal carriage and invasive disease in young children in central Tennessee. J Infect Dis (2001) 1.18
Human immune response to streptococcal inhibitor of complement, a serotype M1 group A Streptococcus extracellular protein involved in epidemics. J Infect Dis (2000) 1.17
Cognitive deficits in parents from multiple-incidence autism families. J Child Psychol Psychiatry (1997) 1.17
Identification and characterization of two nonessential regions of the rabbitpox virus genome involved in virulence. J Virol (1991) 1.15
Role of respiratory tract proteases in infectivity of influenza A virus. J Infect Dis (1987) 1.13
Recombinant expression and characterization of the major beta-lactamase of Mycobacterium tuberculosis. Antimicrob Agents Chemother (1998) 1.12
Social and nonsocial home environments of infants with nonorganic failure-to-thrive. Pediatrics (1984) 1.10
C-reactive protein reactivity with complement and effects on phagocytosis. Ann N Y Acad Sci (1982) 1.10
Cat scratch disease: detection of Bartonella henselae DNA in archival biopsies from patients with clinically, serologically, and histologically defined disease. Am J Pathol (1996) 1.10
Antibiotic therapy for cat-scratch disease? JAMA (1989) 1.08
Enhanced production of recombinant Mycobacterium tuberculosis antigens in Escherichia coli by replacement of low-usage codons. Infect Immun (2000) 1.08
An outbreak of acute rheumatic fever in Tennessee. Pediatr Infect Dis J (1990) 1.07
A role for C-reactive protein in the complement-mediated stimulation of human neutrophils by type 27 Streptococcus pneumoniae. J Immunol (1982) 1.07
BSE: a decade on--Part I. Lancet (1997) 1.07
Unusual arsenate poisoning of the F pili of Escherichia coli. J Bacteriol (1973) 1.07
Craniomandibular osteopathy in a labrador puppy. Vet Rec (1966) 1.06
FCgammaRII (CD32)-dependent induction of interferon-alpha by serum from patients with lupus erythematosus. Eur Cytokine Netw (1999) 1.05
Central venous catheter infections. Pediatr Clin North Am (1988) 1.05
Folded, concatenated genomes as replication intermediates of bacteriophage T7 DNA. J Virol (1977) 1.04
Cardiovascular effects of morphine and opioid peptides following intracisternal administration in chloralose-anesthetized rats. Eur J Pharmacol (1978) 1.04
Lack of comparability between commonly used serological assays of immune response to Haemophilus influenzae vaccine. J Infect Dis (1987) 1.04
Incidence of pertussis infection in healthcare workers. Infect Control Hosp Epidemiol (1999) 1.04
PFAPA syndrome. Pediatr Infect Dis J (1989) 1.04
Serologic response to standard inactivated influenza vaccine in human immunodeficiency virus-infected children. Pediatr Infect Dis J (1994) 1.03
Multifocal osteomyelitis caused by Paecilomyces varioti in a patient with chronic granulomatous disease. Infection (1995) 1.03
Detection of Rochalimaea henselae DNA by polymerase chain reaction from suppurative nodes of children with cat-scratch disease. Pediatr Infect Dis J (1994) 1.03
A new approach to the neurological assessment of the preterm and full-term newborn infant. Brain Dev (1980) 1.03
Characterization of bactericidal immune responses following vaccination with acellular pertussis vaccines in adults. Infect Immun (2000) 1.03
A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children. Pediatrics (1997) 1.03
State mandates and childhood immunization. JAMA (2000) 1.02
BSE: a decade on--Part 2. Lancet (1997) 1.02
Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines. Pediatrics (2000) 1.00
Follow-up of pre-term infants: is correction of the developmental quotient for prematurity helpful? Early Hum Dev (1984) 1.00
Relationship between infant sleep position and motor development in preterm infants. J Dev Behav Pediatr (2001) 1.00
Changing trends and prognostic features in endometrial cancer associated with exogenous estrogen therapy. Obstet Gynecol (1979) 1.00
Monoclonal antibodies against colonization factor antigen I pili from enterotoxigenic Escherichia coli. Infect Immun (1983) 0.99
Presumed congenital myodegeneration in a calf. Vet Rec (1979) 0.99
Mother-to-child transmission of human T-cell lymphotropic virus type I associated with prolonged breast-feeding. J Hum Virol (1999) 0.99
Influenza vaccination in the organ transplant recipient: review and summary recommendations. Am J Transplant (2011) 0.98
Recurrent bacterial infections associated with C3 nephritic factor and hypocomplementemia. N Engl J Med (1983) 0.97